Skip to main content

Table 3 Clinical characteristics of patients with GUTB

From: Serologic and urinary characteristics of laboratory-confirmed genitourinary tuberculosis at a tertiary hospital in the Philippines

Clinical characteristics No. of patients (%) (n = 112)
Gender
 M 52 (46.43%)
 F 60 (53.57%)
Age
 0 months–1 year 1 (0.89%)
 1 year–5 years 2 (1.79%)
 6 years–10 years 4 (3.57%)
 11 years–18 years 18 (16.07%)
 19 years–29 years 21 (18.75%)
 30 years–49 years 35 (31.25%)
 50 years–69 years 27 (24.11%)
 70 years or older 4 (3.57%)
Marital status
 Single/widowed 69 (61.61%)
 Married 43 (38.39%)
Occupation
 Employed 19 (16.96%)
 Unemployed 58 (51.79%)
 Not applicable (i.e., pediatric) 26 (23.21%)
 Unspecified 9 (8.04%)
Location
 Urban 60 (53.57%)
 Rural 48 (42.86%)
 Unspecified 4 (3.57%)
Co-morbidity
Previous TB 14 (12.50%)
Diabetes mellitus 5 (4.46%)
HIV/AIDS 12 (10.71%)
Steroid use (e.g., SLE, NS) 9 (8.04%)
Malignancy 1 (0.89%)
Chronic kidney disease 5 (4.46%)
History of urolithiasis 8 (7.14%)
RTA Type 1 1 (0.89%)
COPD 2 (1.79%)
Bronchial asthma 2 (1.79%)
Hypertension 13 (11.61%)
Heart failure 2 (1.79%)
Cerebrovascular disease 1 (0.89%)
Other organ involvement 64 (57.14%)
Pulmonary 57 (50.89%)
Gastrointestinal 28 (25.00%)
Abdominopelvic 11 (9.82%)
Central nervous system 7 (6.25%)
Bone 4 (3.57%)
Lymph node 8 (7.14%)
Ear 2 (1.79%)
Psoas 2 (1.79%)
Cutaneous/wound 3 (2.68%)
Chief complaint
Weakness 16 (14.29%)
Difficulty of breathing 14 (12.50%)
Flank pain 13 (11.61%)
Abdominal pain 11 (9.82%)
Hematuria 9 (8.04%)
Dysuria 9 (8.04%)
Fever 8 (7.14%)
Abdominal/pelvic mass on diagnostic 5 (4.46%)
Pedal edema 4 (3.57%)
Umbilical discharge 3 (2.68%)
Gluteal pain 2 (1.79%)
Vaginal bleeding 2 (1.79%)
Cough 2 (1.79%)
Seizure 2 (1.79%)
Urinary retention 1 (0.89%)
Inguinal pain 1 (0.89%)
Fistula formation (ureterocutaneous) 1 (0.89%)
Scrotal discharge 1 (0.89%)
Double J stent reinsertion 1 (0.89%)
Decrease in sensorium 1 (0.89%)
Vomiting 1 (0.89%)
Others 5 (4.46%)
  1. COPD chronic obstructive pulmonary disease, F female, HIV/AIDS human immunodeficiency virus or acquired immunodeficiency syndrome, M male, NS nephrotic syndrome, RTA Type 1 renal tubular acidosis Type 1, SLE systemic lupus erythematosus, TB tuberculosis